The drug supply cycle as a strategic function - Hitimana Jacques, Imanirakiza
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

A company's supply cycle is a strategic function for its business. its activities. When it is efficient, it limits disruptions and overstocking, and encourages the profitability profitability, which remains a sine qua non for the long-term survival of any business.Good drug management within a hospital is essential to ensure access to and availability of quality drugs for patients. and availability of quality medicines at affordable prices. Each stage of the cycle must be must be managed efficiently to provide high-quality pharmaceutical services patient safety.This is a retrospective…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A company's supply cycle is a strategic function for its business. its activities. When it is efficient, it limits disruptions and overstocking, and encourages the profitability profitability, which remains a sine qua non for the long-term survival of any business.Good drug management within a hospital is essential to ensure access to and availability of quality drugs for patients. and availability of quality medicines at affordable prices. Each stage of the cycle must be must be managed efficiently to provide high-quality pharmaceutical services patient safety.This is a retrospective analytical study covering the period from March 1, 2022 to March 31, 2023.Our results show that, according to our hypotheses, the majority of our respondents, i.e. 17 agents (85%), considered the budget to be insufficient, while 3 agents (15%) considered it to be sufficient. Tables VIII, XI, XII and XIII, which present the favourable results, demonstrate that the performance indicators and tools for procurement and stock management are regularly maintained, as do the chi-square test results.
Autorenporträt
IMANIRAKIZA HITIMANA Jacques è laureato in Gestione dei servizi sanitari - Gestione delle organizzazioni sanitarie presso l'Institut Supérieur des Techniques Médicales di Goma ed è celibe. L'autore è ricercatore e analista nel campo della salute nella Repubblica Democratica del Congo.